Berino, Ma Corazon E.

HRN: 23-82-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2023
CEFTRIAXONE 1G (VIAL)
10/01/2023
10/07/2023
IV
2gm
Q24H
CAP MR
Checking Final Appropriateness 
10/02/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/02/2023
10/02/2023
IV
4.5
LD
CAP MR
10/02/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/02/2023
10/09/2023
IV
2.25
Q8H
CAP MR
10/03/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/02/2023
10/08/2023
IV
4.5g LD, Then 2.25g
Q8h
CAP HR
Checking Final Appropriateness 
10/05/2023
MUPIROCIN 2%, 15G (TUBE)
10/05/2023
10/08/2023
TOPICAL
2% Small Amount
BID
Blistered Lesion
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: